Abstract:The study of neurological disorders often presents with significant challenges due to the inaccessibility of human neuronal cells for further investigation. Advances in cellular reprogramming techniques, have however provided a new source of human cells for laboratory-based research. Patient-derived induced pluripotent stem cells (iPSCs) can now be robustly differentiated into specific neural subtypes, including dopaminergic, inhibitory GABAergic, motorneurons and cortical neurons. These neurons can then be utilized for in vitro studies to elucidate molecular causes underpinning neurological disease. Although human iPSC-derived neuronal models are increasingly regarded as a useful tool in cell biology, there are a number of limitations, including the relatively early, fetal stage of differentiated cells and the mainly two dimensional, simple nature of the in vitro system. Furthermore, clonal variation is a well-described phenomenon in iPSC lines. In order to account for this, robust baseline data from multiple control lines is necessary to determine whether a particular gene defect leads to a specific cellular phenotype. Over the last few years patient-derived neural cells have proven very useful in addressing several mechanistic questions related to central nervous system diseases, including early-onset neurological disorders of childhood. Many studies report the clinical utility of human-derived neural cells for testing known drugs with repurposing potential, novel compounds and gene therapies, which then can be translated to clinical reality. iPSCs derived neural cells, therefore provide great promise and potential to gain insight into, and treat early-onset neurological disorders.

Neuronal Cell Differentiation of iPSCs for the Clinical Treatment of Neurological Diseases

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Application Potential of Induced Pluripotent Stem Cells in Cell Therapy for Stroke

Inducible pluripotent stem cells for the treatment of ischemic stroke: current status and problems.

Stem Cells for the Treatment of Neurodegenerative Diseases

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.

Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases

Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders

Progress in Therapeutic Use of Neural Stem Cell in Experimental Treatment of Parkinson's Disease

Directional Induction of Neural Stem Cells, a New Therapy for Neurodegenerative Diseases and Ischemic Stroke

iPSC for modeling neurodegenerative disorders

Comparative study of efficacy of dopaminergic neuron differentiation between embryonic stem cell and protein-based induced pluripotent stem cell

Induced pluripotent stem cells for neural drug discovery

Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma

Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells

Enriched Environment and Exercise Enhance Stem Cell Therapy for Stroke, Parkinson's Disease, and Huntington's Disease

Induced Pluripotent Stem Cells and Parkinson's Disease: Modelling and Treatment

Recent advances of induced pluripotent stem cells application in neurodegenerative diseases